Peptide Calculator UK – Reconstitution & Dosage

Peptide Reconstitution & Dosage Calculator

Concentration:
Volume to Draw:
Insulin Units (IU):
Tick Marks:

Quick Unit Conversions

Mass Conversion
mg
mcg
Volume Conversion
mL
IU (U-100)

How the Calculator Works

This calculator performs precise calculations for peptide reconstitution and dosage measurement in laboratory settings. When you reconstitute lyophilised peptides, you create a solution with a specific concentration that determines how much you need to draw for each dose.

Core Formulas:

Concentration (mcg/mL) = (Peptide Amount in mg × 1000) ÷ Water Volume in mL

Volume to Draw (mL) = Desired Dose (mcg) ÷ Concentration (mcg/mL)

Insulin Units = Volume (mL) × 100 (for U-100 syringes)

The calculator automatically converts between units and provides multiple measurement formats including volume in millilitres, insulin units for U-100 syringes, and tick mark positions on your selected syringe size.

Reconstitution Examples

Example 1: 10mg Peptide Vial

Scenario: 10mg peptide vial, need 250 mcg per dose

Method: Add 2mL bacteriostatic water

Result: Concentration = 5000 mcg/mL. Draw 0.05mL (5 IU on U-100 syringe) for 250 mcg dose

Example 2: 5mg Peptide Vial

Scenario: 5mg peptide vial, need 500 mcg per dose

Method: Add 1mL bacteriostatic water

Result: Concentration = 5000 mcg/mL. Draw 0.1mL (10 IU on U-100 syringe) for 500 mcg dose

Example 3: 2mg Peptide Vial

Scenario: 2mg peptide vial, need 100 mcg per dose

Method: Add 2mL bacteriostatic water

Result: Concentration = 1000 mcg/mL. Draw 0.1mL (10 IU on U-100 syringe) for 100 mcg dose

Proper Reconstitution Method

Reconstituting lyophilised peptides requires careful technique to maintain peptide integrity and sterility. Follow these steps for optimal results:

  1. Allow both peptide vial and bacteriostatic water to reach room temperature
  2. Wash hands thoroughly and wear sterile gloves
  3. Remove the centre portion of the peptide vial cap and clean with alcohol swab
  4. Draw the calculated amount of bacteriostatic water into a sterile syringe
  5. Tilt the peptide vial at a 45° angle
  6. Slowly inject water down the inside wall of the vial to minimise foaming
  7. Gently swirl (do not shake) until powder completely dissolves
  8. Allow solution to settle before withdrawing doses
Important: Never inject water directly onto the lyophilised powder as this can damage peptide structure. Always aim for the vial wall and allow the water to gently reconstitute the peptide.

Storage Guidelines

Storage Form Temperature Stability Duration
Lyophilised (unopened) -20°C 3-5 years
Lyophilised (unopened) 4°C Several weeks
Reconstituted solution 4°C 3-4 weeks
Reconstituted solution -20°C 3-4 months
Room temperature (any form) 20°C Not recommended

Lyophilised peptides exhibit remarkable stability when stored properly. Research indicates that freeze-dried peptides maintain full stability for up to 5 years at -80°C. Once reconstituted, peptides become significantly more susceptible to degradation and should be used promptly or stored frozen in aliquots to avoid repeated freeze-thaw cycles.

Syringe Selection Guide

Syringe Size Total Capacity Tick Marks Precision Best For
0.3 mL 30 IU 1 IU per mark Highest Very small doses below 30 mcg
0.5 mL 50 IU 1 IU per mark High Small to medium doses
1.0 mL 100 IU 2 IU per mark Moderate Larger doses and general use

U-100 insulin syringes are the standard for peptide administration in research. The designation U-100 means 100 units per millilitre, making conversion straightforward: 1 mL equals 100 IU, 0.1 mL equals 10 IU, and so forth.

Common Questions

What is the difference between mcg and mg?

Microgrammes (mcg) and milligrammes (mg) are units of mass. 1 mg equals 1,000 mcg. Peptide vials typically contain peptides measured in milligrammes, whilst doses are often specified in microgrammes for precision.

Why use bacteriostatic water instead of sterile water?

Bacteriostatic water contains benzyl alcohol (typically 0.9%), which inhibits bacterial growth. This extends the shelf life of reconstituted peptides and reduces contamination risk when multiple doses are drawn from the same vial over several days or weeks.

How do I know how much water to add?

The amount of water determines your final concentration. More water creates a more dilute solution, requiring larger draw volumes. Less water creates a concentrated solution with smaller draw volumes. Choose a water volume that results in a comfortable draw volume (typically 0.1-0.5 mL) for your intended dose.

Can I reconstitute peptides with normal saline?

Normal saline (0.9% sodium chloride) can be used for some peptides, but bacteriostatic water is preferred for most applications. Certain peptides may require specific solvents based on their chemical properties. Always consult supplier recommendations.

What if my peptide won’t dissolve completely?

Allow adequate time for dissolution (10-15 minutes). Gently swirl, never shake vigorously. If peptide remains undissolved, it may require a different solvent such as acetic acid solution. Some peptides are poorly soluble in water and need alternative reconstitution media.

How accurate are U-100 insulin syringes?

U-100 insulin syringes are highly accurate for volumes above 0.05 mL (5 IU). For smaller volumes, measurement accuracy decreases. When extreme precision is required for very small doses, consider using more concentrated solutions or specialised micro-syringes.

Should I aspirate air bubbles before injecting?

Yes, always remove air bubbles before administration. Tap the syringe gently to move bubbles to the top, then push plunger slightly to expel them. Air bubbles reduce dose accuracy and can cause discomfort.

Can I refreeze reconstituted peptides?

Whilst reconstituted peptides can be frozen, repeated freeze-thaw cycles cause degradation. If you need to freeze reconstituted peptides, divide them into single-use aliquots immediately after reconstitution to avoid multiple freeze-thaw cycles.

Concentration Selection Strategies

Selecting the appropriate concentration involves balancing precision and practicality:

Concentration Range Advantages Disadvantages
High (e.g., 5-10 mg/mL) Small injection volumes, less solution needed Difficult to measure small doses accurately
Medium (e.g., 2-5 mg/mL) Good balance of accuracy and convenience Moderate injection volumes
Low (e.g., 0.5-2 mg/mL) Excellent measurement accuracy for small doses Larger injection volumes, more solution required

For most applications, aim for a concentration that allows you to draw between 0.1 mL and 0.5 mL for your typical dose. This range offers good accuracy with standard insulin syringes whilst keeping injection volumes comfortable.

Troubleshooting Common Issues

Cloudy or turbid solution after reconstitution

Cloudiness may indicate aggregation or precipitation. This can occur if the peptide is poorly soluble in the chosen solvent, if reconstitution was too vigorous, or if the solution pH is unsuitable. Try adjusting the solvent or consult manufacturer guidelines for that specific peptide.

Foam formation during reconstitution

Excessive foaming suggests too-rapid injection or direct injection onto the powder. Always inject slowly against the vial wall at a 45° angle. Allow foam to settle completely before withdrawing doses, as foam contains peptide and affects concentration.

Difficulty drawing solution into syringe

This often results from vacuum in the vial. Before withdrawing solution, inject a small amount of air equal to the volume you plan to withdraw. This equalises pressure and makes drawing easier. Always maintain sterile technique.

Inconsistent dosing between injections

Inconsistency can stem from incomplete mixing, degradation, or measurement errors. Always gently swirl the vial before each dose to redistribute settled peptide. Check that your syringe technique is consistent and verify the solution hasn’t expired.

Safety Considerations

For Research Purposes Only: This calculator and all information provided are intended exclusively for laboratory research applications. Peptides discussed are research chemicals, not approved for human consumption or medical use.
  • Always work in a clean, organised laboratory environment
  • Wear appropriate personal protective equipment including gloves and eye protection
  • Dispose of used syringes and vials in appropriate sharps containers
  • Store all peptides securely away from unauthorised access
  • Maintain detailed records of reconstitution dates, concentrations, and storage conditions
  • Never share reconstitution equipment between different peptides to avoid cross-contamination
  • Label all reconstituted vials clearly with peptide name, concentration, date, and expiry

References

Zapadka KL, Becher FJ, Gomes dos Santos AL, Jackson SE. Factors affecting the physical stability (aggregation) of peptide therapeutics. Interface Focus. 2017;7(6):20170030.
Tang L, Persky AM, Hochhaus G, Meibohm B. Pharmacokinetic aspects of biotechnology products. Journal of Pharmaceutical Sciences. 2004;93(9):2184-2204.
Schein CH. Solubility as a function of protein structure and solvent components. Bio/Technology. 1990;8(4):308-317.
Stevenson CL. Characterization and application of protocols for the control of peptide and protein aggregates. Current Pharmaceutical Biotechnology. 2009;10(7):650-663.
Nugrahadi PP, Hinrichs WLJ, Frijlink HW, Schöneich C, Avanti C. Designing formulation strategies for enhanced stability of therapeutic peptides in aqueous solutions: A review. Pharmaceutics. 2023;15(3):935.
Volkin DB, Middaugh CR. The effect of temperature on protein structure. In: Stability of Protein Pharmaceuticals. Springer; 1992:215-247.
Scroll to Top